Main
>
ONCOLOGY (**)
>
Lymphoma>NHL>B-Cell>DLBCL R/R***
>
Treatment
>
CH. A. CD19. ADC>2 Lines of
>
(*) EU CE Mark Date: 2022. 12.21.
(*) EU CE Mark Date: 2022. 12.21.'s products
This section has no products